1-(9,10-Dihydro-6H-6,10-methanoazepino[4,5-g]-quinoxalin-8(7H)-yl)-2,2,2-trifluoroethanone is a trifluoromethylated pharmaceutical intermediate typically used as protected impurity to prepare varenicline for smoking cessation.
Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation.[1]
Reference:
[1] J.W.Coe, et al, J. Med. Chem., 2005, 48(10), pp 3474-3477.
Signal Word
Hazard Statements
Precautionary Statements
HS Code
RIDADR
Legal Information
Not classified as a hazardous substance or mixture
-yl)-2,2,2-trifluoroethanone.png)
